TrialEuropean journal of endocrinology2017

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.

Anna G Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.